Investigating the Effects of Iron on the Gastrointestinal Tract

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

155 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-09

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Many patients that are prescribed iron report gastrointestinal side effects. This research project aims to investigate if the gastrointestinal symptoms of taking iron supplementation are related to changes in gases produced by bacteria in the gastrointestinal tract.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Probiotics Use and Preventing Gastrointestinal Symptoms in People Living With Overweight and Obesity.

NCT07253155

Gut Inflammation Overweight and Obese Volunteers

ENROLLING_BY_INVITATION NA

Fibre and Gas in Irritable Bowel Syndrome

NCT03265002

Irritable Bowel Syndrome

COMPLETED NA

Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome

NCT02565550

Irritable Bowel Syndrome

UNKNOWN PHASE4

The Effect of Micronutrient Supplementation on Gut Microbiome Composition and Function

NCT05371704

Gastrointestinal Microbiome

UNKNOWN NA

Dark Chocolate and Intestinal Motility

NCT03841578

Gastrointestinal Motility

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a pre-post interventional, two armed prospective cohort study where patients who are newly diagnosed with iron deficiency anaemia are prescribed iron therapy (either oral iron supplements, 200mg capsules containing 65mg of iron 2-3 times daily, or intravenous iron 1000-1500mg) as part of their standard care. Participants will be asked to provide breath samples and complete the IBS-SSS questionnaire at baseline and after 4 weeks of taking the iron therapy as part of their standard care. A diary including stool consistency and frequency will also be completed by participants on a daily basis. For further exploratory research, some participants from each the oral and IV iron arm will be asked to provide stool samples at baseline and 4-weeks post iron therapy to assess any microbiome changes in response to iron therapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iron Deficiency Anemia Constipation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oral iron

These patients will have diagnosed with iron deficiency anaemia and been prescribed oral iron supplements as part of their treatment from their doctor. This will be in accordance with the NICE guidelines; 200mg capsules containing 65mg elemental iron, 2-3 times a day for a period of atleast 1 month.

Fasted breath samples

Intervention Type OTHER

Will be completed pre and post iron therapy

IBS-SSS

Intervention Type OTHER

Will be completed pre and post iron therapy

Daily diary

Intervention Type OTHER

Monitoring stool form, consistency and frequency on a daily basis for 4 weeks

Exploratory research: stool samples

Intervention Type OTHER

Completed pre and post iron therapy for a subset of patients enrolled in the study

Intravenous iron

These patients will have diagnosed with iron deficiency anaemia and been prescribed intravenous iron as part of their treatment from their doctor. Participants will receive an infusion of either 1000mg or 1500mg

Fasted breath samples

Intervention Type OTHER

Will be completed pre and post iron therapy

IBS-SSS

Intervention Type OTHER

Will be completed pre and post iron therapy

Daily diary

Intervention Type OTHER

Monitoring stool form, consistency and frequency on a daily basis for 4 weeks

Exploratory research: stool samples

Intervention Type OTHER

Completed pre and post iron therapy for a subset of patients enrolled in the study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fasted breath samples

Will be completed pre and post iron therapy

Intervention Type OTHER

IBS-SSS

Will be completed pre and post iron therapy

Intervention Type OTHER

Daily diary

Monitoring stool form, consistency and frequency on a daily basis for 4 weeks

Intervention Type OTHER

Exploratory research: stool samples

Completed pre and post iron therapy for a subset of patients enrolled in the study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Written informed consent before participating in the study after being given a full description of the study and prior to any study-specific procedures being performed.
2. Male or non-pregnant female and is age 18 years to 80 years.
3. Can communicate well with the Investigator and to comply with the requirements for the entire study.
4. Capacity to understand written English.
5. New diagnosis iron-deficient anaemia.
6. Prescribed IV iron therapy or oral iron supplementation which contains 65mg elemental iron, two or three times per day for a period of at least 1 month or, will receive 1000mg or 1500mg of intravenous iron, as part of their standard care.
7. Participant agrees to wait until after taking baseline breath samples and completing the IBS-SSS questionnaire before starting their iron therapy.
8. Participant agrees to follow pre-test diet for 24 hours before giving test sample.
9. Participant agrees to refrain from strenuous physical activity on the day of the breath test.
10. Refrain from smoking on the day of the breath test.
11. Agree to complete an overnight fast on the night before the breath test. Food and drink must be withheld until after all breath test samples have been taken.
12. No probiotics for 14 days before the breath test or during the study.
13. Body mass index between 18.5 and 34.9kg/m2 (bounds included).
14. Not antibiotics for 4-weeks before the start of the study or during the study

Exclusion Criteria

1. Using an opioid based medication.
2. Antibiotics in the 4 weeks prior to enrolment.
3. Colonoscopy/sigmoidoscopy in the 1 week prior to enrolment, unless they have taken their baseline breath sample and IBS-SSS questionnaire before completing the required bowel preparation.
4. Diagnosis of any organic gastrointestinal disease, including inflammatory bowel disease, coeliac disease and diverticulitis.
5. Mechanical obstruction of the GI tract.
6. Participant is diabetic.
7. Participant has any hepatic disease.
8. Participant has any disease of the CNS.
9. Participant is involved in this study as an Investigator, sub-Investigator, study coordinator, other study staff, or sponsor member.
10. Previous abdominal or colorectal surgery except appendectomy, cholecystectomy, or hysterectomy.
11. Participant has had iron therapy in the 12 months prior to enrollment.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No